233 related articles for article (PubMed ID: 30717826)
1. HIV-1 Vpu is a potent transcriptional suppressor of NF-κB-elicited antiviral immune responses.
Langer S; Hammer C; Hopfensperger K; Klein L; Hotter D; De Jesus PD; Herbert KM; Pache L; Smith N; van der Merwe JA; Chanda SK; Fellay J; Kirchhoff F; Sauter D
Elife; 2019 Feb; 8():. PubMed ID: 30717826
[TBL] [Abstract][Full Text] [Related]
2. HIV Vpu Interferes with NF-κB Activity but Not with Interferon Regulatory Factor 3.
Manganaro L; de Castro E; Maestre AM; Olivieri K; García-Sastre A; Fernandez-Sesma A; Simon V
J Virol; 2015 Oct; 89(19):9781-90. PubMed ID: 26178989
[TBL] [Abstract][Full Text] [Related]
3. Vpu-Mediated Counteraction of Tetherin Is a Major Determinant of HIV-1 Interferon Resistance.
Kmiec D; Iyer SS; Stürzel CM; Sauter D; Hahn BH; Kirchhoff F
mBio; 2016 Aug; 7(4):. PubMed ID: 27531907
[TBL] [Abstract][Full Text] [Related]
4. Efficient Vpu-Mediated Tetherin Antagonism by an HIV-1 Group O Strain.
Mack K; Starz K; Sauter D; Langer S; Bibollet-Ruche F; Learn GH; Stürzel CM; Leoz M; Plantier JC; Geyer M; Hahn BH; Kirchhoff F
J Virol; 2017 Mar; 91(6):. PubMed ID: 28077643
[TBL] [Abstract][Full Text] [Related]
5. Vpu-mediated tetherin antagonism of ongoing HIV-1 infection in CD4(+) T-cells is not directly related to the extent of tetherin cell surface downmodulation.
Kuhl BD; Sloan RD; Donahue DA; Liang C; Wainberg MA
Virology; 2011 Sep; 417(2):353-61. PubMed ID: 21757214
[TBL] [Abstract][Full Text] [Related]
6. Convergent Evolution of HLA-C Downmodulation in HIV-1 and HIV-2.
Hopfensperger K; Richard J; Stürzel CM; Bibollet-Ruche F; Apps R; Leoz M; Plantier JC; Hahn BH; Finzi A; Kirchhoff F; Sauter D
mBio; 2020 Jul; 11(4):. PubMed ID: 32665270
[TBL] [Abstract][Full Text] [Related]
7. Multilayered and versatile inhibition of cellular antiviral factors by HIV and SIV accessory proteins.
Sauter D; Kirchhoff F
Cytokine Growth Factor Rev; 2018 Apr; 40():3-12. PubMed ID: 29526437
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 Vpu Downmodulates ICAM-1 Expression, Resulting in Decreased Killing of Infected CD4
Sugden SM; Pham TNQ; Cohen ÉA
J Virol; 2017 Apr; 91(8):. PubMed ID: 28148794
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 Vpu does not degrade interferon regulatory factor 3.
Hotter D; Kirchhoff F; Sauter D
J Virol; 2013 Jun; 87(12):7160-5. PubMed ID: 23552418
[TBL] [Abstract][Full Text] [Related]
10. Emerging role of the host restriction factor tetherin in viral immune sensing.
Hotter D; Sauter D; Kirchhoff F
J Mol Biol; 2013 Dec; 425(24):4956-64. PubMed ID: 24075872
[TBL] [Abstract][Full Text] [Related]
11. Stimulation of NF-κB activity by the HIV restriction factor BST2.
Tokarev A; Suarez M; Kwan W; Fitzpatrick K; Singh R; Guatelli J
J Virol; 2013 Feb; 87(4):2046-57. PubMed ID: 23221546
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 Nef and Vpu Interfere with L-Selectin (CD62L) Cell Surface Expression To Inhibit Adhesion and Signaling in Infected CD4+ T Lymphocytes.
Vassena L; Giuliani E; Koppensteiner H; Bolduan S; Schindler M; Doria M
J Virol; 2015 May; 89(10):5687-700. PubMed ID: 25822027
[TBL] [Abstract][Full Text] [Related]
13. The human immunodeficiency virus type 1 Vpu protein inhibits NF-kappa B activation by interfering with beta TrCP-mediated degradation of Ikappa B.
Bour S; Perrin C; Akari H; Strebel K
J Biol Chem; 2001 May; 276(19):15920-8. PubMed ID: 11278695
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 Vpu Promotes Phagocytosis of Infected CD4
Cong L; Sugden SM; Leclair P; Lim CJ; Pham TNQ; Cohen ÉA
mBio; 2021 Aug; 12(4):e0192021. PubMed ID: 34425695
[TBL] [Abstract][Full Text] [Related]
15. Differential sensitivities of tetherin isoforms to counteraction by primate lentiviruses.
Weinelt J; Neil SJ
J Virol; 2014 May; 88(10):5845-58. PubMed ID: 24623426
[TBL] [Abstract][Full Text] [Related]
16. Human-Specific Adaptations in Vpu Conferring Anti-tetherin Activity Are Critical for Efficient Early HIV-1 Replication In Vivo.
Yamada E; Nakaoka S; Klein L; Reith E; Langer S; Hopfensperger K; Iwami S; Schreiber G; Kirchhoff F; Koyanagi Y; Sauter D; Sato K
Cell Host Microbe; 2018 Jan; 23(1):110-120.e7. PubMed ID: 29324226
[TBL] [Abstract][Full Text] [Related]
17. The HIV-1 Accessory Protein Vpu Downregulates Peroxisome Biogenesis.
Xu Z; Lodge R; Power C; Cohen EA; Hobman TC
mBio; 2020 Mar; 11(2):. PubMed ID: 32127461
[TBL] [Abstract][Full Text] [Related]
18. Vpu Exploits the Cross-Talk between BST2 and the ILT7 Receptor to Suppress Anti-HIV-1 Responses by Plasmacytoid Dendritic Cells.
Bego MG; Côté É; Aschman N; Mercier J; Weissenhorn W; Cohen ÉA
PLoS Pathog; 2015 Jul; 11(7):e1005024. PubMed ID: 26172439
[TBL] [Abstract][Full Text] [Related]
19. Vpu-deficient HIV strains stimulate innate immune signaling responses in target cells.
Doehle BP; Chang K; Fleming L; McNevin J; Hladik F; McElrath MJ; Gale M
J Virol; 2012 Aug; 86(16):8499-506. PubMed ID: 22647704
[TBL] [Abstract][Full Text] [Related]
20. Identification of alternatively translated Tetherin isoforms with differing antiviral and signaling activities.
Cocka LJ; Bates P
PLoS Pathog; 2012 Sep; 8(9):e1002931. PubMed ID: 23028328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
